期刊文献+

轻度认知功能障碍患者脑脊液和血清中血红素氧化酶-1含量变化与评分量表的关系 被引量:4

Change in heme oxygenase-1 level in cerebrospinal fluid and serum and its correlation with the rating scale in patients with mild cognitive impairment
原文传递
导出
摘要 目的探讨轻度认知功能障碍(MCI)患者脑脊液和血清中血红素氧化酶-1(HO-1)的含量变化,及其与简易精神状态量表(MMSE)和长沙版蒙特利尔评估量表(MoCA)的相关性,为早期诊断MCI提供依据。方法选择2011年6月至2013年6月我院住院患者,分为MCI组45例和健康对照组85例,收集两组患者的基本资料并进行MMSE和长沙版MoCA量表评估;采用双抗体夹心酶联免疫吸附法(ELISA)检测并比较两组脑脊液和血清中HO-1的含量。结果MCI组35例平均血清HO1含量(612.52±111.48)ng/L,健康对照组67例(384.16±56.86)ng/L,差异有统计学意义(t=2.03,P=0.045);MCI组26例平均脑脊液HO-1含量(631.38±32.17)ng/L,健康对照组66例(480.75±17.98)ng/L,差异有统计学意义(t=4.09,P=0.000)。而MCI组、健康对照组血清HO-1含量和脑脊液HO1含量比较差异均无统计学意义(t=0.14、1.61,P=0.887、0.110)。MCI组患者脑脊液和血清中HO-1含量均与MMSE评分呈正相关(r=0.398、0.363 P=0.044、0.032),与MoCA得分相关性无统计学意义(均P〉0.05);对照组脑脊液和血清中HO—1含量变化均与MMSE评分呈负相关(r=-0.572、-0.285,P=0.000、0.019),脑脊液中HO-1含量与MoCA得分呈负相关(r=-0.440,P=0.000),血清中HO-1含量与MoCA得分相关性无统计学意义(P〉0.05)。两组血清和脑脊液中HO—1含量与年龄的相关性均无统计学意义(均P〉0.05)。结论MCI患者脑脊液和血清HO-1含量均明显高于非MCI者,且HO-1含量变化与MMSE评分成正相关,HO-1升高可提示MCI及认知功能下降,有望成为早期诊断MCI的新的标志物。 Objective To explore the change in heme oxygenase-1 (HO-1) level in cerebrospinal fluid(CSF)and serum in patients with mild cognitive impairment(MCI), and the correlation between HO-1 and the rating scale, to provide a new marker for the diagnosis of MCI. Methods The HO-1 levels in CSF and serum in 45 MCI patients (MCI group) and 85 normal cases (control group) were analyzed with sensitive enzyme linked immunosorbent assays (ELISA). MMSE and MoCA scores were evaluated. Results The level of HO-1 was higher in MCI group than in control group both in CSF [(631.38±32.17)vs(480.75±17.98)ng/ L, P〈0.05], and in serum [(612. 52±111. 48) w (384. 16±56.86)ng/ L, P〈0. 053. The MCI and normal people HO-1 level had no significant difference between CSF group and serum group (P〉0.05). In MCI group, the levels of serum and CSF HO-1 had a positive correlation with MMSE scores ( P〈0.05), but had no obvious correlation with MoCA scores (P〉0.05). In the normal group, the level of HOwl was negatively related with MMSE scores in serum and CSF, and with MoCA scores in CSF (P〈0.05), but no obvious correlation in serum (P 〉0.05). The levels of serum and CSF HO-1 had no obvious correlation with age in both groups (P〉0.05). Conclusions HO-1 concentration in both CSF and serum is significantly higher in MCI group than in normal group, and positively related with MMSE score. Thus the increase of HO-1 concentration in both CSF and/or serum might be a new marker for the diagnosis of MCI.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2014年第6期594-597,共4页 Chinese Journal of Geriatrics
关键词 认知障碍 血红素氧化酶 Cognition disorders Heme oxygenase
  • 相关文献

参考文献20

  • 1Schipper HM, Bennett DA, Liberman A, et al. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment[J]. Neurobiol Aging, 2006, 27: 252-261.
  • 2魏爱宣,徐忠信,郭洪亮,梅春丽,王晓明.慢性脑缺血致认知功能障碍大鼠皮层HIF-1α、HO-1表达的变化[J].中国老年学杂志,2010,30(7):913-915. 被引量:10
  • 3Schipper HM, Bennett DA, Liberman A, et al. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment[J]. Neurobiol Aging, 2006, 27:252-261.
  • 4王鲁宁.老年人轻度认知功能障碍的研究进展[J].中华老年医学杂志,2005,24(1):6-8. 被引量:69
  • 5Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome[J]. Arch Neurol, 1999, 56: 303-308.
  • 6靳慧,丁斌蓉,杨霞,雷曾辉,曾湘良,白松,唐湘祁,涂秋云.北京版MoCA在长沙地区缺血性脑血管病人群中的应用及长沙版MoCA的形成[J].中国神经精神疾病杂志,2011,37(6):349-353. 被引量:62
  • 7Volkel W, Sicilia T, Pahler A, et al. , Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease [J]. Neurochem Int, 2006, 48: 679-686.
  • 8Long J, Liu C, Sun L, et al. , Neuronal mitochondrial toxicity of malondialdehyde: inhibitory effects on respiratory function and enzyme activities in rat brain mitochondria[J]. Neurochem Res, 2009, 34: 786-794.
  • 9Hauptmann S, Scherping I, Drose S, et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice[J].Neurobiol Aging, 2009, 30: 1574-1586.
  • 10Maiese K, Chong ZZ. Insights into oxidative stress and potential novel therapeutic targets {or Alzheimer disease[J].Restor Neurol Neurosci, 2004, 22:87- 104.

二级参考文献26

  • 1刘万里,薛茜,曹明芹,马金凤.用SPSS实现完全随机设计多组比较秩和检验的多重比较[J].地方病通报,2007,22(2):27-29. 被引量:96
  • 2Haripriya D, Sangeetha P, Kanchana A, et al. Modulation of age-associated oxidative DNA damage in rat brain cerebral cortex, striatum and hippocampus by L-carnitine[J]. Exp Gerontol, 2005,40 (3) : 129-135.
  • 3Zhu X, Raina AK, Lee HG, et al. Oxidative stress signalling in Alzheimer's disease[J]. Brain Res, 2004,1000(1-2) :32-39.
  • 4Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF[J]. J Neurochem, 1999, 72(2) :771-776.
  • 5Wang J, Xiong S,.Xie C, et al. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimeres disease[J]. J Neurochem, 2005,93 (4) : 953- 962.
  • 6Lovell MA, Xie C, Markesbery WR. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain[J]. Brain Res, 2000,855 (1): 116-123.
  • 7Iida T, Furuta A, Nishioka K, et al. Expression of 8- oxoguanine DNA glycosylase is reduced and associated with neurofibrillary tangles in Alzheimer' s disease brain[J]. Acta Neuropathol (Berl), 2002,103 (1) : 20- 25.
  • 8Furuta A, Iida T, Nakabeppu Y, et al. Expression of hMTH1 in the hippocampi of control and Alzheimer's disease[J]. Neuroreport, 2001,12(13) :2895-2899.
  • 9Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease[J]. J Neurosci, 1999,19 (6): 1959-1964.
  • 10Nunomura A, Chiba S, Lippa CF, et al. Neuronal RNA oxidation is a prominent feature of familial Alzheimer' s disease[J]. Neurobio Dis, 2004,17 (1)108-113.

共引文献154

同被引文献38

  • 1田金洲,时晶,张学凯,倪敬年,张伯礼,王永炎.2011年美国阿尔茨海默病最新诊断标准解读[J].中国医学前沿杂志(电子版),2011,3(4):91-100. 被引量:63
  • 2符荣,赵甲山,朱贤立,赵洪洋,陈衔城,夏鹰,金复生,季耀东.一氧化碳对缺血脑组织神经细胞胞内Ca^(2+)浓度的影响[J].中国病理生理杂志,2004,20(7):1271-1274. 被引量:8
  • 3周卫东,贾建平,HMSehipper.血浆血红素加氧酶1测定在轻度认知障碍和老年性痴呆中的临床意义[J].中国神经精神疾病杂志,2004,30(4):260-260. 被引量:2
  • 4Jack C. de la Torre,Ineke A. van Rossum,Stephanie Vos,Ron Handels,Pieter Jelle Visser.??Biomarkers as Predictors for Conversion from Mild CognitiveImpairment to Alzheimer-Type Dementia: Implications for Trial Design(J)Journal of Alzheimer’s Disease . 2010 (3)
  • 5Oscar L. Lopez,Eric McDade,Mario Riverol.Evolution of the diagnostic criteria for degenerative and cognitive disorders. Current Opinion . 2011
  • 6Jesus J. Gomar,Maria T. Bobes-Bascaran,Concepcion Conejero-Goldberg.Utility of Combinations of Biomarkers, Cognitive Markers, and Risk Factors to Predict Conversion From Mild Cognitive Impairment to Alzheimer Disease in Patients in the Alzheimer’s Disease Neuroimaging Initiative. Archives of General Psychiatry . 2011
  • 7R Craig-Schapiro,M Kuhn,C Xiong,EH Pickering,J Liu,TP Misko,RJ Perrin,KR Bales,H Soares,AM Fagan,DM Holtzman.Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer’s disease diagnosis and prognosis. PloS one . 2011
  • 8Monge-Argiles JA,Munoz-Ruiz C,Pampliega-Perez A,et al.Biomarkers of Alzheimer’’s disease in the cerebrospinal fluid of Spanish patients with mild cognitive impairment. Neurochemical Research . 2011
  • 9Monge-Argilés J Antonio,Sánchez-Payá José,Mu?oz-Ruiz Carlos,Pampliega-Pérez Ana,Montoya-Gutiérrez Javier,Leiva-Santana Carlos.(Biomarkers in the cerebrospinal fluid of patients with mild cognitive impairment: a meta-analysis of their predictive capacity for the diagnosis of Alzheimer’s disease)Revista de Neurologia . 2010
  • 10William T. Hu,Alice Chen-Plotkin,Steven E. Arnold,Murray Grossman,Christopher M. Clark,Leslie M. Shaw,Eve Pickering,Max Kuhn,Yu Chen,Leo McCluskey,Lauren Elman,Jason Karlawish,Howard I. Hurtig,Andrew Siderowf,Virginia M.-Y. Lee,Holly Soares,John Q. Trojanowski.??Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment(J)Acta Neuropathologica . 2010 (6)

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部